位置:首页 > 蛋白库 > SHUT_HHV1K
SHUT_HHV1K
ID   SHUT_HHV1K              Reviewed;         489 AA.
AC   Q82171; Q77ZF2;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 74.
DE   RecName: Full=Virion host shutoff protein;
DE            Short=Vhs;
DE            EC=3.1.27.-;
GN   Name=UL41;
OS   Human herpesvirus 1 (strain KOS) (HHV-1) (Human herpes simplex virus 1).
OC   Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes;
OC   Herpesvirales; Herpesviridae; Alphaherpesvirinae; Simplexvirus.
OX   NCBI_TaxID=10306;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1312822; DOI=10.1007/bf01317150;
RA   Matis J., Krivjanska M., Rajcani J.;
RT   "Herpes simplex virus type 1 (HSV-1) HSZP interferes also after antibody
RT   neutralization with early shutoff of host protein synthesis induced by HSV-
RT   1 KOS.";
RL   Arch. Virol. 123:209-214(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9311788; DOI=10.1128/jvi.71.10.7157-7166.1997;
RA   Everly D.N. Jr., Read G.S.;
RT   "Mutational analysis of the virion host shutoff gene (UL41) of herpes
RT   simplex virus (HSV): characterization of HSV type 1 (HSV-1)/HSV-2
RT   chimeras.";
RL   J. Virol. 71:7157-7166(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9421879; DOI=10.1023/a:1007915025086;
RA   Vojvodova A., Matis J., Kudelova M., Rajcani J.;
RT   "Herpes simplex virus type 1 (HSV-1) strain HSZP host shutoff gene:
RT   nucleotide sequence and comparison with HSV-1 strains differing in early
RT   shutoff of host protein synthesis.";
RL   Virus Genes 15:155-159(1997).
RN   [4]
RP   INTERACTION WITH HUMAN EIF4H.
RX   PubMed=11581395; DOI=10.1128/jvi.75.21.10272-10280.2001;
RA   Feng P., Everly D.N. Jr., Read G.S.;
RT   "mRNA decay during herpesvirus infections: interaction between a putative
RT   viral nuclease and a cellular translation factor.";
RL   J. Virol. 75:10272-10280(2001).
RN   [5]
RP   INTERACTION WITH HUMAN EIF4A2 AND EIF4H, AND MUTAGENESIS OF ASP-34; ASP-82;
RP   GLU-192; ASP-194; ASP-195; THR-211; ASP-213; THR-214; ASP-215; ASP-261 AND
RP   ARG-435.
RX   PubMed=16014927; DOI=10.1128/jvi.79.15.9651-9664.2005;
RA   Feng P., Everly D.N. Jr., Read G.S.;
RT   "mRNA decay during herpes simplex virus (HSV) infections: protein-protein
RT   interactions involving the HSV virion host shutoff protein and translation
RT   factors eIF4H and eIF4A.";
RL   J. Virol. 79:9651-9664(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=28077645; DOI=10.1128/jvi.02414-16;
RA   Su C., Zheng C.;
RT   "Herpes simplex virus 1 abrogates the cGAS/STING-mediated Cytosolic DNA-
RT   Sensing Pathway via its virion host shutoff protein, UL41.";
RL   J. Virol. 91:0-0(2017).
CC   -!- FUNCTION: Minor structural protein that acts as an endoribonuclease
CC       during lytic infection. Degrades host mRNAs in the cytoplasm by cutting
CC       them at preferred sites, including some in regions of translation
CC       initiation. Together with inhibition of host splicing by ICP27,
CC       contributes to an overall decrease in host protein synthesis. Also,
CC       after the onset of viral transcription, accelerates the turnover of
CC       viral mRNA, thereby facilitating the sequential expression of different
CC       classes of viral genes. Binds translation initiation factors eIF4H,
CC       eIF4AI, and eIF4AII, thereby may interact directly with the translation
CC       initiation complex and thus digest specifically mRNAs. Also impedes
CC       antigen presentation by major histocompatibility complex class I and
CC       class II molecules, inhibits secretion of cytokines that would
CC       otherwise recruit lymphocytes and neutrophils cells to the site of
CC       infection and blocks the activation of dendritic cells. Impedes the
CC       alpha/beta interferon-mediated response to infection by evading the
CC       cGAS/ STING-mediated DNA-sensing pathway and degrading CGAS via its
CC       RNase activity. {ECO:0000269|PubMed:28077645}.
CC   -!- SUBUNIT: Interacts with human EIF4H, EIF4A1 and EIF4A2; interaction
CC       with eIF4AI and EIF4A2 presumably allows Vhs protein to associate with
CC       the eIF4F cap-binding complex. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the herpesviridae VHS protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z72338; CAA96525.1; -; Genomic_DNA.
DR   EMBL; AF007815; AAC58446.1; -; Genomic_DNA.
DR   PRIDE; Q82171; -.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0004540; F:ribonuclease activity; TAS:AgBase.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0039595; P:induction by virus of catabolism of host mRNA; IEA:UniProtKB-KW.
DR   GO; GO:0039657; P:suppression by virus of host gene expression; IEA:UniProtKB-KW.
DR   GO; GO:0039503; P:suppression by virus of host innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0046774; P:suppression by virus of host intracellular interferon activity; IMP:AgBase.
DR   InterPro; IPR029060; PIN-like_dom_sf.
DR   InterPro; IPR006086; XPG-I_dom.
DR   Pfam; PF00867; XPG_I; 1.
DR   SUPFAM; SSF88723; SSF88723; 1.
PE   1: Evidence at protein level;
KW   Decay of host mRNAs by virus; Endonuclease;
KW   Eukaryotic host gene expression shutoff by virus;
KW   Host gene expression shutoff by virus; Host mRNA suppression by virus;
KW   Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus;
KW   Interferon antiviral system evasion; Late protein; Nuclease; RNA-binding;
KW   Viral immunoevasion; Virion.
FT   CHAIN           1..489
FT                   /note="Virion host shutoff protein"
FT                   /id="PRO_0000283698"
FT   REGION          110..135
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          142..161
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          285..317
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          333..363
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         34
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         82
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         192
FT                   /note="E->Q: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         194
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         195
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         211
FT                   /note="T->A: Complete loss of human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         211
FT                   /note="T->S: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         213
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         214
FT                   /note="T->I: Complete loss of human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         215
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         261
FT                   /note="D->N: No effect on human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
FT   MUTAGEN         435
FT                   /note="R->H: Complete loss of human eIF4H binding."
FT                   /evidence="ECO:0000269|PubMed:16014927"
SQ   SEQUENCE   489 AA;  54952 MW;  57C38A6186545B5E CRC64;
     MGLFGMMKFA HTHHLVKRQG LGAPAGYFTP IAVDLWNVMY TLVVKYQRRY PSYDREAITL
     HCLCRLLKVF TQKSLFPIFV TDRGVNCMEP VVFGAKAILA RTTAQCRTDE EASDVDASPP
     PSPITDSRPS SAFSNMRRRG TSLASGTRGT AGSGAALPSA APSKPALRLA HLFCIRVLRA
     LGYAYINSGQ LEADDACANL YHTNTVAYVY TTDTDLLLMG CDIVLDISAC YIPTINCRDI
     LKYFKMSYPQ FLALFVRCHT DLHPNNTYAS VEDVLRECHW TPPSRSQTRR AIRREHTSSR
     STETRPPLPP AAGGTEMRVS WTEILTQQIA GGYEDDEDLP LDPRDVTGGH PGPRSSSSEI
     LTPPELVQVP NAQLLEEHRS YVASRRRHVI HDAPESLDWL PDPMTITELV EHRYIKYVIS
     LIGPKERGPW TLLKRLPIYQ DIRDENLARS IVTRHITAPD IADRFLEQLR TQAPPPAFYK
     DVLAKFWDE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024